Authors: J. Latta 1; E. Ehler 1; J. Zámečník 2 Authors‘ workplace: Neurologická klinika, Pardubická krajská nemocnice, a. s., 2Ústav patologie a molekulární medicíny, UK 2. LF a FN Motol, Praha 1 Published in: Cesk Slov Neurol N 2009; 72/105(4): 373-377 Category: Case Report
A 52 - ye ar - old still he althy man developed, over several weeks, a myalgic syndrome with fatigue and muscle we akness, tingling and fasciculati on, predominantly in the lower limbs. Such disorders ca used inability to walk independently. Upon admissi on, the clinical findings included muscle we akness and muscle stiffness with tenderness, a utonomic symptoms with swe ating, intermittent tachycardi a, constipati on, and also personality and behavi oral changes with insomni a and late - night confusi on. The electromyography showed a persisting activity with discharges, which were provoked by voluntary activity, and in particular by the stimulati on of motor fibres. The pati ent was tre ated with carbamazepine and methylprednisolone. Hypertoni a, myalgi a and central symptoms subsided. At that stage, the results came back with highly elevated antibodi es against voltage - gated potassi um channels in serum. However, the pati ent suddenly di ed of malignant arrhythmi a.
Key words: neuromyotonia – Morvan’s disease – voltage-gated potassium channels – arrhythmia – myokymia – fasciculation
1. Fahn S, Jankovic J. Principles and practice of movement disorders. Philadelphi a: Churchill Livingstone Elsevi er 2007.
2. Kadaňka Z, Bednařík J. Ne uromyotoni e – nová kanalopati e. Cesk Slov Ne urol N 2000; 63/ 96(3): 128 – 133.
3. Liguori R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P et al. Morvan’s syndrome: peripheral and central nervo us system and cardi ac involvement with antibodi es to voltage - gated potassi um channels. Brain 2001; 124(12): 2417 – 2426.
4. Lee EK, Maselli RA, Ellis WG, Agi us MA. Morvan’s fibrillary chore a: a parane oplastic manifestati on of thymoma. J Ne urol Ne urosurg Psychi atry 1998; 65(6): 857 – 862.
5. Bajaj BK, Shrestha S. An interesting case report of Morvan’s syndrome from the Indi an subcontinent. Ne urol Indi a 2007; 55(1): 67 – 69.
6. Oh SJ. Principles of clinical electromyography. Case studi es. Baltimore: Willi ams & Wilkins 1993.
7. Valls - Solé J, Montero J. Role of EMG evalu ati on in muscle hyperactivity syndromes. J Ne urol 2004; 251(3): 251 – 260.
8. Han IK, Newsom - Davis J. Ne uromyotoni a (Isaacs‘ Syndrome). In: Lane RJM (ed). Handbo ok of Muscle Dise ase. 1st ed. New York: Informa He althcare 1996 : 355 – 363.
9. Gutmann L, Gutmann L. Myokymi a and ne uromyotoni a. J Ne urol 2004; 251(2): 138 – 142.
10. Maddison P. Ne uromyotoni a. Clin Ne urophysi ol 2006; 117(10): 2118 – 2127.
11. Bednarík J, Kadanka Z. Voliti onal and stimulati on induced ne uromyotonic discharges: unusu al electrophysi ological pattern in acquired ne uromyotoni a. J Ne urol Ne urosurg Psychi atry 2001; 70(3): 406 – 407.
12. Arimura K, Arimura Y, Ng A, Uehara A, Nakae M, Osame M et al. The origin of spontane o us discharges in acquired ne uromyotoni a. A Macro EMG study. Clin Ne urophysi ol 2005; 116(8): 1835 – 1839.
13. Nodera H, Kaji R. Nerve excitability testing and its clinical applicati on to ne uromuscular dise ases. Clin Ne urophysi ol 2006; 117(9): 1902 – 1916.
14. Kle opa KA, Elman LB, Lang B, Vincent A, Scherer SS. Ne uromyotoni a and limbic encephalitis sera target mature Shaker‑type K+ channels: subunit specificity correlates with clinical manifestati ons. Brain 2006; 129(6): 1570 – 1584.
15. Irani S, Lang B. Auto antibody - medi ated disorders of the central nervo us system. Auto immunity 2008; 41(1): 55 – 65.
16. Hart I, Vincent A, Willison H. Ne uromyotoni a. In: Engel A. Myastheni a Gravis and Myasthenic Disorders. Oxford: Oxford University Press US 1999 : 230.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
